Evidence map›Paper›PMID 41371653›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Home Intravenous Heparin Therapy via a Central Venous Port for Recurrent Cancer-associated Stroke Requiring Repeat Mechanical Thrombectomy.

Tomoaki Kameda, Shunichi Okada, Risa Suzuki, Takahito Nishihira, Akito Mori, Yasuhiro Hidaka, Tadataka Kawakami, Shigeru Fujimoto

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomoaki KamedaDepartment of Neurology, Shin-Oyama City Hospital, Japan.
Shunichi OkadaDepartment of Neurology, Shin-Oyama City Hospital, Japan.
Risa SuzukiDepartment of Neurology, Shin-Oyama City Hospital, Japan.
Takahito NishihiraDepartment of Neurology, Shin-Oyama City Hospital, Japan.
Akito MoriDepartment of Neurology, Shin-Oyama City Hospital, Japan.
Yasuhiro HidakaDepartment of Gastroenterology, Shin-Oyama City Hospital, Japan.
Tadataka KawakamiDepartment of Neurology, Shin-Oyama City Hospital, Japan.
Shigeru FujimotoDivision of Neurology, Department of Medicine, Jichi Medical University, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer-associated stroke (CAS) presents significant challenges regarding secondary prevention. A 48-year-old woman with pancreatic cancer experienced two episodes of large-vessel occlusion stroke was treated by mechanical thrombectomy. Subcutaneous heparin was discontinued owing to skin reactions, and recurrence occurred despite the use of a direct oral anticoagulant. As an alternative, intravenous heparin was initiated at home via a chemotherapy port, using a portable infusion pump. This individualized approach was implemented without any major complications, and it may represent a practical option for patients with CAS who are either intolerant or refractory to conventional therapies.

Indexed as

AnticoagulantsHeparinPancreatic NeoplasmsStrokeThrombectomyFemaleHumansMiddle AgedRecurrenceAnticoagulantsHeparincancer-associated strokehome intravenous heparinrepeat mechanical thrombectomy

Identifiers

PMID41371653
PMCPMC13447690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.